Cancer Research
Belantamab Mafodotin Combos Show Promise in Relapsed Multiple Myeloma Trial
GSK's Phase 1/2 trial tests belantamab mafodotin paired with standard regimens in patients who failed prior myeloma therapy.
Clinical Trial
Jun 9, 2026 0
Results for "Bempedoic Acid" in Cancer
20 articles
Cancer Research
Cancer Trial Tests Novel Immune Booster BAY 2416964 With Pembrolizumab
Researchers tested a new drug combination targeting immune suppression in advanced solid tumors before early termination.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Amgen's PSMA Bispecific T-Cell Engager Acapatamab Tested in Advanced Prostate Cancer
Phase 1 trial of acapatamab, a PSMA-targeting bispecific T-cell engager, enrolls 212 men with metastatic castration-resistant prostate cancer.
Clinical Trial
May 13, 2026 0
Cancer Research
Apalutamide Plus Immunotherapy Combo Trial for Rare Prostate Cancer Variant Terminated
A Phase 2 trial testing AR blockade combined with PD-1 inhibition in treatment-emergent neuroendocrine prostate cancer was terminated early.
Clinical Trial
May 15, 2026 0
Cancer Research
Low-Dose Ipilimumab Plus Pembrolizumab Targets Melanoma Brain Metastases
A completed Phase II trial tests whether combining two checkpoint inhibitors can safely and effectively treat melanoma that has spread to the brain.
Clinical Trial
May 7, 2026 0
Cancer Research
Phase I Trial Tests Triple Drug Combo for BRAF-Mutant Metastatic Solid Tumors
MD Anderson researchers evaluated vemurafenib, cetuximab, and irinotecan together to find the optimal dose and safety profile for advanced solid tumors.
Clinical Trial
Jun 5, 2026 0
Cancer Research
HDAC Inhibitor Plus Checkpoint Blocker Tested in Advanced Lung Cancer Trial
A phase 1/2 trial combined mocetinostat and durvalumab in 83 patients with advanced solid tumors and NSCLC.
Clinical Trial
May 7, 2026 0
Cancer Research
L-Arginine Tested to Restore Erectile Function in Prostate Cancer Radiation Survivors
A phase II trial explores whether the amino acid L-arginine, with or without enzyme inhibitors, can improve erectile function and quality of life after prostate cancer radiation therapy.
Clinical Trial
May 29, 2026 0
Cancer Research
Melanoma Drug Resistance Linked to Cellular Communication Vesicles Called Exosomes
French researchers studied how tiny cellular packages called exosomes may help melanoma cells resist treatment and spread throughout the body.
Clinical Trial
Mar 28, 2026 0
Cancer Research
New Cancer Immunotherapy IBI346 Shows Promise in Multiple Myeloma Trial
Small trial tests innovative treatment IBI346 for blood cancer patients who didn't respond to standard therapies.
Clinical Trial
Mar 28, 2026 1
Cancer Research
NCI Trial of Dual Immunotherapy Bintrafusp Alfa for Bladder Cancer Terminated Early
A Phase II NCI trial testing bintrafusp alfa in metastatic urothelial carcinoma was terminated after enrolling only 2 patients.
Clinical Trial
May 21, 2026 0
Cancer Research
Pfizer Tests Novel CD47-PD-L1 Bispecific Antibody in Advanced Solid Tumors
A first-in-human Phase 1 trial evaluates PF-07257876, a dual-checkpoint bispecific antibody targeting both CD47 and PD-L1, in hard-to-treat cancers.
Clinical Trial
May 21, 2026 0
Cancer Research
ISB 1442 Trial for Relapsed Multiple Myeloma Terminated Early
A first-in-human Phase 1/2 trial of ISB 1442 in relapsed/refractory multiple myeloma was halted before completion.
Clinical Trial
Jun 9, 2026 0
Cancer Research
MOBIDERM Compression Panty Tested for Pelvic and Genital Lymphedema Relief
A completed exploratory trial evaluates whether a specialized compression garment can reduce discomfort and improve quality of life in pelvic lymphedema patients.
Clinical Trial
Jun 14, 2026 0
Cancer Research
Triple Drug Combo Targets Richter's Syndrome in Completed Phase 2 Trial
A phase 2 trial tests obinutuzumab, ibrutinib, and venetoclax in Richter's syndrome, a deadly CLL transformation with few treatment options.
Clinical Trial
Jun 4, 2026 0
Cancer Research
Combo Immunotherapy Plus Liver Embolization Targets Metastatic Uveal Melanoma
A phase II trial tests ipilimumab and nivolumab paired with immunoembolization against liver-spread uveal melanoma.
Clinical Trial
Jun 6, 2026 0
Cancer Research
Dual Checkpoint Blockade Plus FOLFOX Chemo Tested in Metastatic Colorectal Cancer
A Phase 1/2 trial tests whether combining durvalumab, tremelimumab, and FOLFOX chemotherapy can safely boost immune response in mCRC.
Clinical Trial
May 17, 2026 0
Cancer Research
Triple Combo Therapy Targets Chemo-Resistant Colorectal Cancer in Phase I Trial
A completed phase I trial tests regorafenib plus dual checkpoint inhibitors in 39 patients with hard-to-treat metastatic colorectal cancer.
Clinical Trial
May 9, 2026 0
Cancer Research
PULSAR Radiation Plus IMSA101 Immunotherapy Trial in Oligoprogressive Cancers Terminated Early
A Phase 2 trial combining adaptive stereotactic radiotherapy with IMSA101 and checkpoint inhibitors was halted after enrolling only 16 patients.
Clinical Trial
May 14, 2026 0
Cancer Research
Online Mindfulness Program Shows Promise for Gynecological Cancer Patients
A Swiss feasibility trial tests digital mindfulness-based cancer recovery, tracking psychosocial outcomes, medication use, and biological markers.
Clinical Trial
May 16, 2026 0
Page 1 of 2Next